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Telomeres are complex protein–DNA structures located at the ends of eukaryotic chromosomes. In a normal cell, telomere
DNA shortens with cell divisions. Such a telomere loss may act as a mitotic clock to eventually signal cell cycling exit and
cellular senescence. In a transversal study, we found a marked decrease in telomere length of peripheral blood mononuclear
cells in HIV-infected patients with advanced immunodeficiency. This telomere reduction concerns T4, T8, and B lymphocytes,
providing evidence of high turnover of these cells in the course of HIV infection. These data suggest that replicative
senescence could be involved in the final immunosuppression and may have important therapeutical implications. q 1997
Academic Press
INTRODUCTION skin dermal and epidermal cells, colon epithelia, and
peripheral blood leukocytes (Allsopp et al., 1992; Buch-
Telomeres form a complex protein–DNA structure at
kovich and Greider, 1996; Counter et al., 1992; Harley et
the ends of eukaryotic chromosomes. Human telomeric
al., 1990; Slagboom et al., 1994; Vaziri et al., 1994). The
DNA consists of several kilobases of simple hexameric
generation of an immune response requires a substantial
repeats (TTAGGG)n . Telomeres protect chromosomes expansion of clones specific for the antigen. Telomerase
from degradation, prevent end to end fusions, rearrange-
activity in human hematopoietic progenitor cells might
ments, and chromosome loss, and are involved in cellular
increase upon proliferation and differentiation (Hiyama
proliferative capacity (Blackburn, 1991; Greider, 1994;
et al., 1995). T and B lymphocytes have telomerase activ-
Harley and Villeponteau, 1995). Changes in the structure
ity that increases after stimulation and decreases with
and function of human telomeres are thought to play a
aging (Buchkovich and Greider, 1996; Hiyama et al., 1995;
role in malignant transformation and cellular senescence
Igarashi and Sakaguchi, 1996). However, the question of
(Harley, 1991). Because DNA polymerases synthesize
its precise function in these cells remains unanswered
DNA in the 5* to 3* direction and require an RNA primer
because telomeres shorten with age in hematopoietic
for initiation, each cell division and DNA replication re-
progenitor cells (CD34/CD380/lo) and in peripheral blood
sults in a loss of 50–100 terminal nucleotides from each
lymphocytes (Vaziri et al., 1993, 1994). Furthermore, it
chromosome (Allsopp et al., 1992; Harley et al., 1990;
has been demonstrated that memory CD4/ T cells have
Vaziri et al., 1993). At some critical telomere lengths the
shorter telomere lengths than naive CD4/ T cells from
ability of a cell to undergo further divisions is compro-
the same donor in correlation with a lower replicative
mised and growth is arrested. Germline cells and almost
capacity in culture (Weng et al., 1995).
all tumor cell lines express telomerase, a specialized
During the course of HIV infection, a general state of
ribonucleoprotein polymerase that extends the 3* end of
activation of the immune system characterizes the long
telomeres. Thus these cells balance telomere loss with
clinically latent period that precedes the profound im-
de novo synthesis through an indefinite number of cell
mune suppression observed in AIDS patients. In asymp-
divisions. In contrast, most of the normal somatic cells
tomatic HIV-infected patients, host immune defenses
express low or undetectable telomerase activity (Hiyama
control the viral replication only partially: billions of vi-
et al., 1995). The length of telomeres has been shown to
ruses are produced per day, and it has been proposed
decrease with cell division in vitro and with increasing
that as a counterpart billions of CD4/ T cells are also
age in vivo for normal human somatic cells, including
produced and destroyed per day (Ho et al., 1995; Wei et
al., 1995). This important cell turnover may concern not
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ergy has been proposed (Lewis et al., 1994). We thus RESULTS
investigated the telomere length of peripheral blood
Marked decrease of telomere lengths of PBMCs frommononuclear cells (PBMC) from HIV-infected patients in
patients with less than 200 T4 lymphocytes/mm3order to evaluate the impact of HIV infection on PBMC
mitotic division and to assess possible involvement of As previously described, TRF of individual donors are
cellular senescence in the immune suppression. highly variable, reflecting in part genetic polymorphism
(Slagboom et al., 1994; Vaziri et al., 1994). Thus, mean
MATERIALS AND METHODS TRF lengths of control PBMCs ranged from 7.73 to 12.68
kb, with a median value of 10.28 kb. We did not find
Cell preparations any significant difference between mean TRF lengths of
controls and HIV-infected patients with more than 200PBMC were isolated by density gradient centrifugation
T4 lymphocytes/mm3 (Fig. 1). On the other hand, meanwith Ficoll–Hypaque from 30 HIV-1-infected patients
TRF lengths of PBMCs from HIV-infected patients withwhose ages ranged from 31 to 41 years (except P1 to
less than 200 T4 lymphocytes/mm3 were significantlyP4) and from 13 seronegative donors of matched ages.
shorter than those of age-matched control donorsTen HIV-infected patients had a CD4 cell count of more
(Mann–Whitney test: P  0.0002). Standard deviation ofthan 200 cells/mm3 (P1 to P10) and 20 of less than 200
mean TRF length determination was approximately 500cells/mm3 (P11 to P30) (Table 1). Cell separations were
bp. The median of the mean TRF lengths of patientsperformed using specific magnetic microspheres coated
with less than 200 T4 lymphocytes/mm3 was 7.5 kb, thuswith monoclonal antibodies directed against either the
largely lower than the median value of age-matched con-CD4 (T4 lymphocytes), the CD8 (T8 lymphocytes), or the
trol patients (Fig. 1). When considering the clinical statusCD19 (B lymphocytes) antigens (Dynabeads, Dynal, Nor-
according to CDC classification (1993), similar resultsway) according to the manufacturer’s recommendations.
were obtained with a significant decrease in PBMC te-
lomere lengths of stage C patients (data not shown).Mean telomere restriction fragment (TRF) length
Because of the highly interindividual variability of te-determination
lomere lengths, our transversal study did not allow us
High-molecular-weight genomic DNA was directly ex- to determine if PBMC telomere reduction concerns all
tracted on fresh cells without a congelation step and patients with less than 200 CD4/ cells/mm3. However,
digested by RsaI (10 U) and HinfI (10 U). Digested DNA the fact that none of these patients had PBMC telomere
(1 mg/well) was separated by electrophoresis (50 V for lengths reaching the median value of controls suggests
14 hr) in a 0.5% agarose gel and then transferred onto a that telomere length reduction concerns a majority of
nylon membrane (Hybond N, Amersham) and fixed by these patients.
UV. Hybridization was carried out with a 32P-end-labeled Patients with less than 200 CD4/ cells/mm3 could be
(CCCTAA)7 for 16 hr at 507. Membranes were then either further separated into two groups according to the pre-
exposed to MolecularImager screens overnight and ana- dominant cell population in their PBMCs: group A (P12,
lyzed by Molecular Analysis 2.1 software or revealed by P14, P16, P18, P22, P23, P24, P27, P28, and P30) had a
autoradiography (Hyperfilm MP, Amersham) with a majority of T8 lymphocytes, and group B (P11, P15, P17,
screen intensifier at 0807. Time exposure of autoradiog- P20, P25, and P29) a majority of B lymphocytes in their
raphy was performed to avoid film saturation. The autora- PBMCs. The respective mean TRF lengths of PBMC of
diogram was scanned and densitometric profiles were these two groups were also significantly lower than
obtained with NIH Image 1.60. Densitometric profiles mean TRF lengths of PBMCs of control patients (Mann–
were expressed in gray levels (GL). Mean TRF length Whitney test: P  0.0005 and P  0.0104, respectively;
was calculated as the center of mass of the densitomet- Fig. 1). The difference between group A and group B was
ric profile not significant. These observations suggest that telomere
length reduction may concern both T8 and B lympho-
cytes.∑
i
GL(xi)
(i GL(xi)
L(xi),
T4, T8, and B lymphocyte telomere lengths decrease
in HIV-infected patients with advanced
with xi as the distance from the wells and L(xi) the migra- immunodeficiency
tion function giving the length of a DNA fragment at xi .
Parameters of L(xi) (Oerter et al., 1990) were calculated In order to determine precisely which cells are con-
cerned in telomere length reduction, we then investi-by nonlinear regression with ProFit (Cherwell Scientific,
Oxford). All statistical analysis was performed using Stat- gated mean TRF lengths of separated T4, T8, and B lym-
phocytes.View 4.02 software (Abacus Concept inc.) on mean TRF
lengths from age-matched controls and HIV-infected pa- In controls, we found no significant difference of mean
TRF length between T4 and T8 lymphocytes, suggestingtients (31–41 years old).
AID VY 8512 / 6a33$$$$$2 03-31-97 22:46:12 viral AP: Virology
150 POMMIER ET AL.
FIG. 1. PBMC telomere lengths of seronegative controls and HIV-infected patients separated according to their circulating CD4/ T cell count.
The horizontal lines are the medians of each distribution. The square boxes contain 50% of the data centered around the median. The vertical lines
begin at the 10th percentile and end at the 90th percentile. Each data point below the 10th percentile or above the 90th percentile is plotted
individually. Patients with less than 200 cells/mm3 were further separated into two groups according to their predominant cell population in their
PBMCs: group A, P12, P14, P16, P18, P22, P23, P24, P27, P28, and P30, with a majority of T8 lymphocytes; and group B, P11, P15, P17, P20, P25,
and P29. P values were determined using the Mann–Whitney test by comparison with the control group.
that these two circulating cell populations have the same B cells from one of these patients (P9) had higher mean
TRF lengths than T lymphocytes as observed in controlspattern of replicative history in a normal donor (Fig. 2).
In contrast, for each donor, B lymphocytes had higher (Table 1, Fig. 2).
On the other hand, TRF lengths of T8 and B cells ofmean TRF lengths than T lymphocytes.
In 8/8 HIV-infected with more than 200 CD4/ cells/ HIV-infected patients with less than 200 CD4/ cells/mm3
were significantly reduced compared to those of age-mm3, mean TRF lengths were similar between T4 and
T8 lymphocytes (Fig. 2). Furthermore, values obtained for matched controls (Mann–Whitney test: P  0.063 and P
 0.0424, respectively) (Table 1 and Fig. 2). We found nopatients P5 to P9 (patients whose ages range from 31 to
41 years; Table 1) were comparable to those of age- correlation between telomere lengths and the percent-
ages of respective lymphocyte subpopulations in patientmatched control donors. Altogether, these data provide
no evidence of T lymphocyte telomere length decrease PBMCs. None of these patients had a T8 lymphocyte
mean TRF length greater than the lowest value foundin patients with more than 200 CD4/ cells/mm3, confirm-
ing our previous data obtained on PBMCs. In addition, among controls, suggesting strongly that T8 lymphocyte
FIG. 2. Comparison of mean TRF lengths of T4, T8, and B lymphocytes from controls and HIV-1-infected patients with more or less than 200
cells/mm3.
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TABLE 1
Mean TRF Lengths of PBMCs from HIV-Infected Patients and Control Donors
PBMC CD4/ CD8/ B cells
Mean Mean Mean Mean
TRF TRF TRF TRF
Age Lymphocyte CD4/ cell CD8/ cell lengths lengths lengths lengths
Patients (years) Main clinical events count/mm3 T3% count/mm3 count/mm3 (kb) (kb) (kb) (kb)
P1 23 Adenopathy 1400 82 434 686 8.99 10.01
P2 24 Asymptomatic 1700 85 323 1088 11.42 12.08
P3 24 Asymptomatic 1300 79 338 611 9.9 10.61
P4 29 Asymptomatic 2800 89 614 1792 9.31 9.35 9.7
P5 31 Mycosis 1800 87 522 1008 9.15 8.45 8.64
P6 32 Asymptomatic 1900 82 665 855 9.8 8.79 9.98
P7 33 Tuberculosis — — 840 — 9.99
P8 34 Asymptomatic 700 83 259 322 9.28 9.16 10.93
P9 35 Asymptomatic 1600 96 496 896 11.44 10.69 10.58
P10 41 Asymptomatic — — 364 — 8.51
P11 31 HIV encephalopathy, toxoplasmic 300 20 2 48 7.93 7.8 7.28
encephalitis
P12 31 HIV encephalopathy bacterial 300 68 12 182 7.02
pneumonia, recurrent
P13 32 Diarrhea 400 33 4 116 8.51 9.36
P14 31 Mycosis 1300 82 169 858 6.48 7.17
P15 33 CMV encephalitis Mycobacterium 100 43 4 39 7.15
avium– intracellular complex
infection
P16 34 Toxoplasmic encephalitis 900 85 9 747 7.73
P17 34 Toxoplasmic encephalitis 100 20 1 18 6.62
P18 34 Vacuolar myelopathy 200 55 20 98 6.66
P19 35 Bronchitis 800 73 136 448 6.48 7.45
P20 35 HIV encephalopathy 200 41 12 66 7.52
P21 35 Oral candidosis 600 37 12 204 6.6 9.34
P22 36 HIV encephalopathy 200 71 20 116 7.92
P23 36 Kaposi Sarcoma 1400 69 8 854 8.24
Toxoplasmic encephalitis
P24 37 Toxoplasmic encephalitis 700 53 4 357 6.59
Pneumocystis carinii pneumonia,
candida oesophagitis, VZV
retinitis
P25 37 Progressive multifocal 500 47 2 215 8.49
leukoencephalopathy
P26 Asymptomatic 900 33 72 207 6.37 5.89
P27 38 Meningitis 1800 82 126 1278 7 6.44 7.39 9.55
P28 41 Asymptomatic 2800 96 176 2408 6.97
P29 41 PCP, CMV retinitis 300 45 10 90 8.72
P30 41 Asymptomatic 1400 83 98 1036 7.5 6.76 7.62
C1 31 10.55
C2 32 10.68
C3 32 10.28 9.01 9.19 11.22
C4 33 10.24
C5 34 8.66 9.53 9.81
C6 34 8.35 7.94 8.67 9.14
C7 36 12.68
C8 36 8.76
C9 36 10.26 9.76 13.11
C10 37 10.62 9.01 8.7 11.81
C11 38 7.93
C12 39 7.73
C13 41 11.65
telomere shortening may be a general event in patients the lowest value found among age-matched controls.
Due to the extreme interindividual variability of TRF,with advanced infection. Three of six patients (P13, P21,
P27) have a B lymphocytes mean TRF length greater than these observations do not signify the lack of telomere
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length reduction of B lymphocytes in these patients. Fur- struction of dividing T4 lymphocytes compensated by an
influx of naive cells. Indeed, it has been demonstratedthermore, it should be noted that two patients (P11 and
P26) have telomeres of their B lymphocytes shorter than that in a normal donor, memory CD4/ CD45RO/ T cells
have shorter telomere lengths than naive CD4/ CD45RA/those of their T8 lymphocytes (Table 1), indicative of a
dramatic decrease in B lymphocyte telomere lengths in T cells (Weng et al., 1995). Thus whole CD4/ T cell te-
lomere length is a function of the replicative history ofthese patients.
Mean TRF lengths of T4 lymphocytes were determined these two T4 lymphocyte subpopulations. Dividing T4
lymphocytes have been shown to be highly prone to HIVfor three patients with less than 200 CD4/ cells/mm3,
and the values obtained were lower than those of their infection and destruction (Schnittman et al., 1990). Under
those conditions, naive T4 lymphocytes, upon activationB and/or T8 lymphocytes and significantly lower than
those of age-matched control donors (Table 1). Thus our and differentiation into cells expressing a memory phe-
notype and memory cells, are preferentially killed. Duringdata suggest that telomere shortening may concern T4,
T8, and B lymphocytes in patients with advanced immu- the course of the disease, this would thus lead to the
progressive loss of cells that have undergone a highnodeficiency.
number of divisions compared to naive cells and finally
contribute to the apparent stability of CD4/ T cell te-DISCUSSION
lomere lengths. In this view, it would be interesting to
determine the respective mean TRF lengths of cells ex-The rate of loss of PBMC telomeric DNA has been
evaluated to be approximately 40 bp/year in a normal pressing naive and memory phenotypes in the course of
HIV infection. Furthermore, mean TRF lengths of progeni-donor (Vaziri et al., 1993). Thus the 2.78-kb difference
between PBMC mean TRF lengths of controls and pa- tors have been shown to decrease with age (Vaziri et al.,
1994). Therefore, a high influx of naive cells required bytients with less than 200 CD4/ cells/mm3 is particularly
significant of an early cellular aging of circulating im- immune activation and T4 lymphocyte destruction, but
also by an intense T8 lymphocyte turnover, may acceler-mune cells in HIV-infected patients with advanced immu-
nodeficiency. In a recent study, Effros et al. (1996) found ate this phenomenon and contributes also to the stability
of T4 lymphocyte telomere length. Thus the lack of te-only a minor difference (less than 1 kb) between mean
telomere lengths of PBMCs of control donors and pa- lomere length reduction of T4 lymphocytes in patients
with more than 200 T4 lymphocytes/mm3 does not dis-tients at various stages of HIV infection. Our results dem-
onstrate that when assessed in patients with advanced agree with a high rate of T4 cell divisions and destruction
proposed by Ho et al. (1995), but would be its directinfection, PBMC telomere shortening is largely more pro-
nounced. Indeed, we found no significant difference in consequence.
Contrary to Wolthers et al. (1996), who investigatedPBMC telomere lengths between controls and HIV-in-
fected patients with more than 200 cells/mm3. However, four patients with less than 200 CD4/ T cell/mm3, we
found for three of three patients with advanced HIV infec-rather than a final event, PBMC telomere shortening may
be progressive during the course of the infection. Re- tion a marked shortening of CD4/ T cell telomeres. Con-
sistent with our results, Effros et al. (1996) also investi-cently, in a longitudinal study Wolthers et al. (1996) found
a 1 to 2 kb telomere length decrease in PBMC of some gated one patient with less than 200 CD4/ T cells/mm3
(Patient SP2) and found a significant decrease in CD4/patients with more than 200 CD4/ after several years of
HIV infection. This phenomenon cannot be excluded in T lymphocyte telomere length compared to that of his
CD8/ T cells. A final decline in T4 lymphocyte telomeresome of our patients but cannot be evidenced in our
transversal study. lengths in the course of HIV infection may originate in an
accelerated shortening of telomere lengths of progenitorWolthers et al. (1996) observed that CD8/ T cell TRF
length decreased whereas CD4/ T cell TRF length re- cells, which may be in part involved in the impaired clo-
nogenesis observed in HIV-infected patients (De Luca etmained stable during the course of HIV infection. As
described by Wolthers et al. (1996), we did not observe al., 1993) and leads to the progressive limitation of their
replenishment capacity. This would suggest that replica-any significant reduction of telomere length of CD4/ T
cells in patients with more than 200 CD4/ T cells/mm3. tive senescence could be involved in the final CD4/ T
lymphocyte depletion. However, the reasons for the dis-Wolthers et al. (1996) proposed that the lack of reduction
of CD4/ T cell telomere lengths in HIV-infected patients crepancies between our results and those of Wolthers
et al. (1996) remain unclear and require further analysisindicates that ‘‘the bulk of the CD4/ T cells in HIV-infected
men is turning over at the same rate as in healthy per- of a larger number of patients.
Our demonstration of an important turnover of immunesons’’ and ‘‘do not support the idea of high rates of pro-
duction and destruction of CD4/ T cells as depicted by cells, which concerns not only CD4/ T cells, but also T8
and B lymphocytes, is consistent with the description ofHo et al. (1995).’’ For us, the lack of reduction of CD4/ T
cell telomere lengths in HIV-infected patients with more a chronic state of activation of the immune system in
HIV-infected patients. HIV infection results in generalizedthan 200 CD4/ T cells/mm3 could be interpreted rather
as the consequence of a progressive and massive de- hypergammaglobulinemia, in an increased number of ac-
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tivated circulating B cells, and in B cell hyperplasia in Pelicci et al., 1986; Bacchetti, 1995). We may also assume
that telomere shortening could be involved in the loss oflymph nodes (Martinez-Maza et al., 1987; Pelicci et al.,
1986; Yarchoan et al., 1986). As the clinical latency period specific anti-HIV CTL activity which has been proposed
to be determinant for the progression of the diseaseproceeds, CD8/ T cells that express activation molecules
such as CD38 and DR increase (Salazar-Gonzalez et al., (Pantaleo et al., 1990). Indeed, the intense viral replica-
tion occurring during the asymptomatic phase may accel-1985). In addition, the percentage of CD8/DR/ T lympho-
cytes in the proliferative (S-G2-M) phase of the cell cycle erate senescence of the specific anti-HIV CTL and thus
allow the virus to totally overcome the host immune de-was shown to be higher in infected patients compared
with controls (Mahalingam et al., 1995). This important fenses. Moreover, high turnover of CD4/ T cell, but also
of CD8/ T cell, lymphocytes may accelerate cellularcell turnover could be the consequence of an antigen-
induced T cell activation or the consequence of the in- aging of their progenitors, diminishing progressively their
replenishment capacity. Immunosenescence could thustense cytokine production occurring in infected patients.
CD8/DR/ lymphocytes in AIDS patients are severely play a major role in the final immunodeficiency. These
considerations may have important therapeutical impli-defective in their potential expansion in vitro following
stimulation with various mitogens such as PHA, which cations.
suggests anergy (Margolick et al., 1985). Our observa-
tions suggest that impaired proliferative capacity of CD8/ ACKNOWLEDGMENT
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